↓ Skip to main content

Sumatriptan (rectal route of administration) for acute migraine attacks in adults

Overview of attention for article published in Cochrane database of systematic reviews, February 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sumatriptan (rectal route of administration) for acute migraine attacks in adults
Published in
Cochrane database of systematic reviews, February 2012
DOI 10.1002/14651858.cd009664
Pubmed ID
Authors

Christopher J Derry, Sheena Derry, R Andrew Moore

Abstract

Migraine is a highly disabling condition for the individual and also has wide-reaching implications for society, healthcare services, and the economy. Sumatriptan is an abortive medication for migraine attacks, belonging to the triptan family. Rectal administration may be preferable to oral for individuals experiencing nausea and/or vomiting.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 24%
Student > Master 10 20%
Student > Bachelor 4 8%
Unspecified 3 6%
Professor 2 4%
Other 5 10%
Unknown 13 27%
Readers by discipline Count As %
Chemistry 12 24%
Agricultural and Biological Sciences 9 18%
Engineering 7 14%
Unspecified 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 1 2%
Unknown 13 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2015.
All research outputs
#6,475,007
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,776
of 8,923 outputs
Outputs of similar age
#49,956
of 117,346 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 121 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,346 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.